This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
11-01 :: December 2010 / January 2011


nanotimes


Companies Facts


expected, initially, to have the capacity to produ- ce around 25kg of cadmium-free quantum dots (CFQD™) annually.


Commercial-scale batches of high quality red CFQD™ have been successfully manufactured during commissioning. Nanoco is now trialling batches for a specific customer application and expects to be able to deliver 1kg of red CFQD™ to the customer within the next few months. Once validated by the custo- mer, this will, subject to the Company’s satisfaction of certain other contractual terms and conditions, trigger a $2m milestone payment. The Company also anticipates shipping 1kg of green CFQD™ in mid 2011, subject to similar terms and conditions.


Furthermore, Nanoco Group announced the comple- tion of a total of 16,700,000 new ordinary shares in the capital of Nanoco. The shares have been placed with institutions at a price of 89 pence per Placing Share. Based on the Placing Price, the gross proceeds of the Placing will be approximately £15 million ($24 million). http://www.nanocogroup.com/


T


he German manufacturer of high-precision optical 3D surface analysis tools NanoFocus AG


(Frankfurt: N2F) starts the product development of a new sensor generation with a major contract from the medical technology industry. The optical sensors in the high end segment will become part of a new product family implementing most recent, state-of- the-art technology.


The order is one milestone of a long-term roadmap with high revenue potential for NanoFocus. The bulk order for the medical sensor provides alongside the


recent capital increase a stable foundation for finan- cing further product development and other projects within this area.


“This is a big step towards series production,” says Jürgen Valentin, Managing Board Technology of NanoFocus AG. http://www.nanofocus.info


N


anogate AG (ISIN DE000A0JKHC9), Germany, has initiated a strategic partnership with Kapy-


fract AG, a major player in Europe’s tunnel fireproo- fing industry. The objective of the partnership is to internationally market and implement innovative coating solutions for traffic tunnels based on Nano- gate-Technologie®


33


. Together, the two companies will


tap the significant market potential available Euro- pean-wide and offer customers a one-stop shop for premium-quality products and services for coating concrete. In recent months, with this in mind, Nano- gate has considerably ramped up its product experti- se and given Kapyfract access to this know-how. The first joint systems are now available by the name of KapyCoat E+. http://www.nanogate.de


N


anoLogix (PINK OTC Markets: NNLX), an innovator in the accelerated detection and


identification of microorganisms, announced the current 300 patient trial of NanoLogix GBS (Group B Streptococcus) Quick Tests is ongoing at the Uni- versity of Texas Health Science Center (UTHSC) in Houston. NanoLogix anticipates initial filings for GBS Quick-Test FDA approval following final publica- tion of the GBS trial results. In addition, this month UTHSC Houston plans to expand its evaluation of NanoLogix Quick Tests, concurrent with the GBS


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95
Produced with Yudu - www.yudu.com